These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26171588)

  • 1. TIGIT expression levels on human NK cells correlate with functional heterogeneity among healthy individuals.
    Wang F; Hou H; Wu S; Tang Q; Liu W; Huang M; Yin B; Huang J; Mao L; Lu Y; Sun Z
    Eur J Immunol; 2015 Oct; 45(10):2886-97. PubMed ID: 26171588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling.
    Li M; Xia P; Du Y; Liu S; Huang G; Chen J; Zhang H; Hou N; Cheng X; Zhou L; Li P; Yang X; Fan Z
    J Biol Chem; 2014 Jun; 289(25):17647-57. PubMed ID: 24817116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.
    Yin X; Liu T; Wang Z; Ma M; Lei J; Zhang Z; Fu S; Fu Y; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
    Front Immunol; 2018; 9():2341. PubMed ID: 30364127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell Ig and ITIM domain regulates natural killer cell activation in murine acute viral hepatitis.
    Bi J; Zhang Q; Liang D; Xiong L; Wei H; Sun R; Tian Z
    Hepatology; 2014 May; 59(5):1715-25. PubMed ID: 24319005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIGIT safeguards liver regeneration through regulating natural killer cell-hepatocyte crosstalk.
    Bi J; Zheng X; Chen Y; Wei H; Sun R; Tian Z
    Hepatology; 2014 Oct; 60(4):1389-98. PubMed ID: 24912841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-9 Expression Defines a Subpopulation of NK Cells with Impaired Cytotoxic Effector Molecules but Enhanced IFN-γ Production, Dichotomous to TIGIT, in HIV-1 Infection.
    Motamedi M; Shahbaz S; Fu L; Dunsmore G; Xu L; Harrington R; Houston S; Elahi S
    Immunohorizons; 2019 Nov; 3(11):531-546. PubMed ID: 31732662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth
    Zhou XM; Li WQ; Wu YH; Han L; Cao XG; Yang XM; Wang HF; Zhao WS; Zhai WJ; Qi YM; Gao YF
    Front Immunol; 2018; 9():2821. PubMed ID: 30555485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1, CTLA-4, LAG-3, and TIGIT: The roles of immune checkpoint receptors on the regulation of human NK cell phenotype and functions.
    Esen F; Deniz G; Aktas EC
    Immunol Lett; 2021 Dec; 240():15-23. PubMed ID: 34599946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells.
    Vendrame E; Seiler C; Ranganath T; Zhao NQ; Vergara R; Alary M; Labbé AC; Guédou F; Poudrier J; Holmes S; Roger M; Blish CA
    AIDS; 2020 May; 34(6):801-813. PubMed ID: 32028328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TX99 Is a Neutralizing Monoclonal Antibody Against Mouse TIGIT.
    Nakamura Y; Naito K; Yamashita-Kanemaru Y; Komori D; Hirochika R; Shibuya A; Shibuya K
    Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):105-109. PubMed ID: 29648914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.
    Sarhan D; Cichocki F; Zhang B; Yingst A; Spellman SR; Cooley S; Verneris MR; Blazar BR; Miller JS
    Cancer Res; 2016 Oct; 76(19):5696-5706. PubMed ID: 27503932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of TIGIT in Natural Killer Cell Exhaustion and Immune Escape in Patients and Mouse Model With Liver Echinococcus multilocularis Infection.
    Zhang C; Wang H; Li J; Hou X; Li L; Wang W; Shi Y; Li D; Li L; Zhao Z; Li L; Aji T; Lin R; Shao Y; Vuitton DA; Tian Z; Sun H; Wen H
    Hepatology; 2021 Dec; 74(6):3376-3393. PubMed ID: 34192365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIGIT Signaling Pathway Regulates Natural Killer Cell Function in Chronic Hepatitis B Virus Infection.
    Wang J; Hou H; Mao L; Wang F; Yu J; Luo Y; Lin Q; Sun Z
    Front Med (Lausanne); 2021; 8():816474. PubMed ID: 35265633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIGIT immune checkpoint blockade enhances immunity of human peripheral blood NK cells against castration-resistant prostate cancer.
    Wang F; Liu S; Liu F; Xu T; Ma J; Liang J; Wang J; Liu D; Yang F; Li J; Xing N
    Cancer Lett; 2023 Aug; 568():216300. PubMed ID: 37414394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions.
    Xu F; Sunderland A; Zhou Y; Schulick RD; Edil BH; Zhu Y
    Cancer Immunol Immunother; 2017 Oct; 66(10):1367-1375. PubMed ID: 28623459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.
    Yu J; Wei M; Becknell B; Trotta R; Liu S; Boyd Z; Jaung MS; Blaser BW; Sun J; Benson DM; Mao H; Yokohama A; Bhatt D; Shen L; Davuluri R; Weinstein M; Marcucci G; Caligiuri MA
    Immunity; 2006 May; 24(5):575-90. PubMed ID: 16713975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The paired receptors TIGIT and DNAM-1 as targets for therapeutic antibodies.
    Stein N; Tsukerman P; Mandelboim O
    Hum Antibodies; 2017; 25(3-4):111-119. PubMed ID: 28035916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of TIGIT and PD-1 expression on NK cells during the course of normal pregnancy.
    Wang Y; Li D; Yu T; Hu M; Xing J; Bai S; Qu W; Tong X
    Immunol Lett; 2021 Feb; 230():42-48. PubMed ID: 33359535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer.
    Maas RJ; Hoogstad-van Evert JS; Van der Meer JM; Mekers V; Rezaeifard S; Korman AJ; de Jonge PK; Cany J; Woestenenk R; Schaap NP; Massuger LF; Jansen JH; Hobo W; Dolstra H
    Oncoimmunology; 2020 Nov; 9(1):1843247. PubMed ID: 33224630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients.
    Kong Y; Zhu L; Schell TD; Zhang J; Claxton DF; Ehmann WC; Rybka WB; George MR; Zeng H; Zheng H
    Clin Cancer Res; 2016 Jun; 22(12):3057-66. PubMed ID: 26763253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.